Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
START: Sorafenib vs TACE + Radiotherapy in Hepatocellular Carcinoma
NCT01901692Phase 3Completed
- Sponsor
- Asan Medical Center
- Start
- Jul 2013
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Asan Medical Center. Started Jul 2013; status: completed.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01901692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01901692.